Search

Savitha M. Rao

Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )

Most Active Art Unit
1629
Art Unit(s)
1629, 1614, 1621, 1691, 4131
Total Applications
1525
Issued Applications
872
Pending Applications
108
Abandoned Applications
583

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6321067 [patent_doc_number] => 20100113472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'COMPOUNDS FOR THE TREATMENT OF OSTEOPOROSIS AND CANCERS' [patent_app_type] => utility [patent_app_number] => 12/611766 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18053 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113472.pdf [firstpage_image] =>[orig_patent_app_number] => 12611766 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/611766
COMPOUNDS FOR THE TREATMENT OF OSTEOPOROSIS AND CANCERS Nov 2, 2009 Abandoned
Array ( [id] => 8846073 [patent_doc_number] => 08455252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Materials and methods for sensitizing multidrug resistant cells' [patent_app_type] => utility [patent_app_number] => 13/125530 [patent_app_country] => US [patent_app_date] => 2009-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 10119 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125530 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/125530
Materials and methods for sensitizing multidrug resistant cells Oct 23, 2009 Issued
Array ( [id] => 6551727 [patent_doc_number] => 20100233248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'CLAY-BASED HEMOSTATIC AGENTS AND DEVICES FOR THE DELIVERY THEREOF' [patent_app_type] => utility [patent_app_number] => 12/581782 [patent_app_country] => US [patent_app_date] => 2009-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7282 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233248.pdf [firstpage_image] =>[orig_patent_app_number] => 12581782 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/581782
Clay-based hemostatic agents and devices for the delivery thereof Oct 18, 2009 Issued
Array ( [id] => 7574076 [patent_doc_number] => 20110269732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'DRUG DISCOVERY METHODS' [patent_app_type] => utility [patent_app_number] => 12/595878 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17513 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269732.pdf [firstpage_image] =>[orig_patent_app_number] => 12595878 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/595878
DRUG DISCOVERY METHODS Oct 13, 2009 Abandoned
Array ( [id] => 6256961 [patent_doc_number] => 20100029591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/574881 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9600 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029591.pdf [firstpage_image] =>[orig_patent_app_number] => 12574881 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/574881
Combinations of a pyrimidine containing NNRTI with RT inhibitors Oct 6, 2009 Issued
Array ( [id] => 6359436 [patent_doc_number] => 20100087416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'AEROSOL FLUOROQUINOLONE FORMULATIONS FOR IMPROVED PHARMACOKINETICS' [patent_app_type] => utility [patent_app_number] => 12/574680 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18602 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087416.pdf [firstpage_image] =>[orig_patent_app_number] => 12574680 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/574680
Aerosol fluoroquinolone formulations for improved pharmacokinetics Oct 5, 2009 Issued
Array ( [id] => 6426017 [patent_doc_number] => 20100151509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'REAGENT, KIT AND METHOD FOR DIFFERENTATING AND COUNTING LEUKOCYTES' [patent_app_type] => utility [patent_app_number] => 12/568500 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10640 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151509.pdf [firstpage_image] =>[orig_patent_app_number] => 12568500 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/568500
Reagent, kit and method for differentiating and counting leukocytes Sep 27, 2009 Issued
Array ( [id] => 8921013 [patent_doc_number] => 08486949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Use of azaperone for improving growth performance' [patent_app_type] => utility [patent_app_number] => 13/119733 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2867 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119733 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/119733
Use of azaperone for improving growth performance Sep 16, 2009 Issued
Array ( [id] => 7977641 [patent_doc_number] => 08071567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => '4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication' [patent_app_type] => utility [patent_app_number] => 12/561097 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10592 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071567.pdf [firstpage_image] =>[orig_patent_app_number] => 12561097 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/561097
4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication Sep 15, 2009 Issued
Array ( [id] => 6578254 [patent_doc_number] => 20100273893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'PROTECTIVE EFFECT OF THYMOQUINONE IN SPESIS' [patent_app_type] => utility [patent_app_number] => 12/560587 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3938 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273893.pdf [firstpage_image] =>[orig_patent_app_number] => 12560587 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/560587
Protective effect of thymoquinone in sepsis Sep 15, 2009 Issued
Array ( [id] => 8374943 [patent_doc_number] => 08257731 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Devices and methods for the delivery of molecular sieve materials for the formation of blood clots' [patent_app_type] => utility [patent_app_number] => 12/555876 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 3357 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12555876 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/555876
Devices and methods for the delivery of molecular sieve materials for the formation of blood clots Sep 8, 2009 Issued
Array ( [id] => 7776382 [patent_doc_number] => 20120039917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'IMMUNOMODULATING ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 13/061112 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10178 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039917.pdf [firstpage_image] =>[orig_patent_app_number] => 13061112 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/061112
IMMUNOMODULATING ACTIVITIES Aug 27, 2009 Abandoned
Array ( [id] => 9086423 [patent_doc_number] => 08557852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Methods of using crystalline forms of a salt of a factor Xa inhibitor' [patent_app_type] => utility [patent_app_number] => 12/550291 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10989 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12550291 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/550291
Methods of using crystalline forms of a salt of a factor Xa inhibitor Aug 27, 2009 Issued
Array ( [id] => 7501864 [patent_doc_number] => 20110263642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/737917 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 32333 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263642.pdf [firstpage_image] =>[orig_patent_app_number] => 12737917 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/737917
METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS Aug 25, 2009 Abandoned
Array ( [id] => 6307301 [patent_doc_number] => 20100069420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'SPIRO-PIPERIDINE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/545501 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9369 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069420.pdf [firstpage_image] =>[orig_patent_app_number] => 12545501 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/545501
Spiro-piperidine inhibitors Aug 20, 2009 Issued
Array ( [id] => 5373761 [patent_doc_number] => 20090311322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'ATORVASTATIN FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/544120 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5537 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311322.pdf [firstpage_image] =>[orig_patent_app_number] => 12544120 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/544120
ATORVASTATIN FORMULATION Aug 18, 2009 Abandoned
Array ( [id] => 6478837 [patent_doc_number] => 20100092443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'NOVEL COMBINATIONS OF NITROGENATED HETEROCYCLIC ANTIBACTERIAL COMPOUNDS WITH OTHER ANTIBACTERIAL COMPOUNDS AND THE USE OF SAME AS DRUGS' [patent_app_type] => utility [patent_app_number] => 12/535865 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13188 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092443.pdf [firstpage_image] =>[orig_patent_app_number] => 12535865 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/535865
NOVEL COMBINATIONS OF NITROGENATED HETEROCYCLIC ANTIBACTERIAL COMPOUNDS WITH OTHER ANTIBACTERIAL COMPOUNDS AND THE USE OF SAME AS DRUGS Aug 4, 2009 Abandoned
Array ( [id] => 6289824 [patent_doc_number] => 20100158895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS' [patent_app_type] => utility [patent_app_number] => 12/534935 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 34994 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158895.pdf [firstpage_image] =>[orig_patent_app_number] => 12534935 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/534935
METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS Aug 3, 2009 Abandoned
Array ( [id] => 6412256 [patent_doc_number] => 20100166735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS' [patent_app_type] => utility [patent_app_number] => 12/534928 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 34994 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166735.pdf [firstpage_image] =>[orig_patent_app_number] => 12534928 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/534928
METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS Aug 3, 2009 Abandoned
Array ( [id] => 6290409 [patent_doc_number] => 20100159004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS' [patent_app_type] => utility [patent_app_number] => 12/534946 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 34990 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20100159004.pdf [firstpage_image] =>[orig_patent_app_number] => 12534946 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/534946
METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS Aug 3, 2009 Abandoned
Menu